Your browser doesn't support javascript.
loading
HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
Bareng, Ontlametse T; Moyo, Sikhulile; Zahralban-Steele, Melissa; Maruapula, Dorcas; Ditlhako, Tsotlhe; Mokaleng, Baitshepi; Mokgethi, Patrick; Choga, Wonderful T; Moraka, Natasha O; Pretorius-Holme, Molly; Mine, Madisa O; Raizes, Elliot; Molebatsi, Kesaobaka; Motswaledi, Modisa S; Gobe, Irene; Mohammed, Terence; Gaolathe, Tendani; Shapiro, Roger; Mmalane, Mompati; Makhema, Joseph M; Lockman, Shahin; Essex, Max; Novitsky, Vlad; Gaseitsiwe, Simani.
Afiliação
  • Bareng OT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Moyo S; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
  • Zahralban-Steele M; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Maruapula D; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Ditlhako T; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Mokaleng B; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Mokgethi P; Department of Biological Sciences, Faculty of Science, University of Botswana, Gaborone, Botswana.
  • Choga WT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Moraka NO; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Pretorius-Holme M; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
  • Mine MO; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Raizes E; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Molebatsi K; Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Motswaledi MS; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Gobe I; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.
  • Mohammed T; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Gaolathe T; Botswana Ministry of Health and Wellness, Gaborone, Botswana.
  • Shapiro R; U.S. Centers for Disease Control and Prevention, Atlanta, USA.
  • Mmalane M; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Makhema JM; Department of Statistics, University of Botswana, Gaborone, Botswana.
  • Lockman S; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
  • Essex M; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
  • Novitsky V; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
J Antimicrob Chemother ; 77(5): 1385-1395, 2022 04 27.
Article em En | MEDLINE | ID: mdl-35229102
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article